相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Nicotinic acid as a lipid-modifying drug - A review
U. Julius et al.
ATHEROSCLEROSIS SUPPLEMENTS (2013)
被撤回的出版物: Primary Prevention of Cardiovascular Disease with a Mediterranean Diet (Retracted article. See vol. 378, pg. 2441, 2018)
Ramon Estruch et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Effects of Physical Activity on Cardiovascular Disease
Haitham M. Ahmed et al.
AMERICAN JOURNAL OF CARDIOLOGY (2012)
Antithrombotic Therapy in Peripheral Artery Disease Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines
Pablo Alonso-Coello et al.
CHEST (2012)
Primary and Secondary Prevention of Cardiovascular Disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (vol 141, pg e637S, 2012)
Per Olav Vandvik
CHEST (2012)
Short- Versus Long-Term Duration of Dual-Antiplatelet Therapy After Coronary Stenting A Randomized Multicenter Trial
Marco Valgimigli et al.
CIRCULATION (2012)
Medical Therapy in Peripheral Artery Disease
Jeffrey S. Berger et al.
CIRCULATION (2012)
Renal Sympathetic Denervation for Treatment of Drug-Resistant Hypertension One-Year Results From the Symplicity HTN-2 Randomized, Controlled Trial
Murray D. Esler et al.
CIRCULATION (2012)
Atherothrombotic Disease, Traditional Risk Factors, and 4-Year Mortality in a Latin American Population: The REACH Registry
Carlos Cantu-Brito et al.
CLINICAL CARDIOLOGY (2012)
A Point-by-Point Response to Recent Arguments Against the Use of Statins in Primary Prevention This Statement Endorsed by the American Society for Preventive Cardiology
Parag H. Joshi et al.
CLINICAL CARDIOLOGY (2012)
European Guidelines on cardiovascular disease prevention in clinical practice (version 2012)
Joep Perk et al.
TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY (2012)
Comparison of Novel Risk Markers for Improvement in Cardiovascular Risk Assessment in Intermediate-Risk Individuals
Joseph Yeboah et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)
2012 ACCF/AHA Focused Update of the Guideline for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction (Updating the 2007 Guideline and Replacing the 2011 Focused Update) A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
Hani Jneid et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2012)
The Controversies of Statin Therapy Weighing the Evidence
J. Wouter Jukema et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2012)
Thiazide diuretics in advanced chronic kidney disease
Rajiv Agarwal et al.
JOURNAL OF THE AMERICAN SOCIETY OF HYPERTENSION (2012)
Association Between Longer Therapy With Thiazolidinediones and Risk of Bladder Cancer: A Cohort Study
Ronac Mamtani et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2012)
Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: an analysis from the JUPITER trial
Paul M. Ridker et al.
LANCET (2012)
Toward “Pain-Free” Statin Prescribing: Clinical Algorithm for Diagnosis and Management of Myalgia
Terry A. Jacobson
MAYO CLINIC PROCEEDINGS (2012)
Nicotine replacement therapy for smoking cessation
Lindsay F. Stead et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2012)
European Guidelines on cardiovascular disease prevention in clinical practice (version 2012)
Joep Perk et al.
EUROPEAN HEART JOURNAL (2012)
Primary and Secondary Prevention of Cardiovascular Disease Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines
Olav Vandvik et al.
CHEST (2012)
AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2011 Update A Guideline From the American Heart Association and American College of Cardiology Foundation Endorsed by the World Heart Federation and the Preventive Cardiovascular Nurses Association
Sidney C. Smith et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2011)
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions
Glenn N. Levine et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2011)
Statins and safety: can we finally be reassured?
Payal Kohli et al.
LANCET (2011)
Associations between C-reactive protein, coronary artery calcium, and cardiovascular events: implications for the JUPITER population from MESA, a population-based cohort study
Michael J. Blaha et al.
LANCET (2011)
The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial
Colin Baigent et al.
LANCET (2011)
The Million Hearts Initiative - Preventing Heart Attacks and Strokes
Thomas R. Frieden et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin Therapy
William E. Boden et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Guidelines for the Prevention of Stroke in Patients With Stroke or Transient Ischemic Attack A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association
Karen L. Furie et al.
STROKE (2011)
Lipoprotein(a) and ischemic heart disease-A causal association? A review
Pia R. Kamstrup
ATHEROSCLEROSIS (2010)
Aspirin for Prevention of Cardiovascular Events in a General Population Screened for a Low Ankle Brachial Index A Randomized Controlled Trial
F. Gerald R. Fowkes et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
2010 ACCF/AHA Guideline for Assessment of Cardiovascular Risk in Asymptomatic Adults A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
Philip Greenland et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
Atherogenic Dyslipidemia: Cardiovascular Risk and Dietary Intervention
Kiran Musunuru
LIPIDS (2010)
Dose Comparisons of Clopidogrel and Aspirin in Acute Coronary Syndromes
NEW ENGLAND JOURNAL OF MEDICINE (2010)
The ACCORD Study Group. Effects of combination lipid therapy in type 2 diabetes mellitus.
Lukasz Januszkiewicz
KARDIOLOGIA POLSKA (2010)
Effects of Intensive Blood-Pressure Control in Type 2 Diabetes Mellitus
William C. Cushman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Effects of Combination Lipid Therapy in Type 2 Diabetes Mellitus
Henry N. Ginsberg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
A Convenient Tool to Profile Patients for Generalized Cardiovascular Disease Risk in Primary Care
S. Rasika Wickramasinghe et al.
AMERICAN JOURNAL OF CARDIOLOGY (2009)
Predicting the 30-Year Risk of Cardiovascular Disease The Framingham Heart Study
Michael J. Pencina et al.
CIRCULATION (2009)
Combination therapy of statins and fibrates in the management of cardiovascular risk
Catherine Fievet et al.
CURRENT OPINION IN LIPIDOLOGY (2009)
The Association Between A1C and Subclinical Cardiovascular Disease The Multi-Ethnic Study of Atherosclerosis
Marguerite J. McNeely et al.
DIABETES CARE (2009)
Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials
LANCET (2009)
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
Lars Wallentin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Coronary artery calcification compared with carotid intima-media thickness in the prediction of cardiovascular disease incidence - The Multi-Ethnic Study of Atherosclerosis (MESA)
Aaron R. Folsom et al.
ARCHIVES OF INTERNAL MEDICINE (2008)
Greater clinical benefit of more intensive oral antiplatelet therapy with prasugrel in patients with diabetes mellitus in the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel-Thrombolysis in Myocardial Infarction 38
Stephen D. Wiviott et al.
CIRCULATION (2008)
General cardiovascular risk profile for use in primary care - The Framingham Heart Study
Ralph B. D'Agostino et al.
CIRCULATION (2008)
Low-Dose Aspirin for Primary Prevention of Atherosclerotic Events in Patients With Type 2 Diabetes A Randomized Controlled Trial
Hisao Ogawa et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
Effects of intensive glucose lowering in type 2 diabetes
Hertzel C. Gerstein et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Benazepril plus Amlodipine or Hydrochlorothiazide for Hypertension in High-Risk Patients
Kenneth Jamerson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
Paul M. Ridker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Weight loss with a low-carbohydrate, Mediterranean, or low-fat diet
Iris Shai et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
The prevention of progression of arterial disease and diabetes (POPADAD) trial: factorial randomised placebo controlled trial of aspirin and antioxidants in patients with diabetes and asymptomatic peripheral arterial disease
Jill Belch et al.
BMJ-BRITISH MEDICAL JOURNAL (2008)
Nicotine receptor partial agonists for smoking cessation
Kate Cahill et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2008)
Using pedometers to increase physical activity and improve health - A systematic review
Dena M. Bravata et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Prasugrel versus clopidogrel in patients with acute coronary syndromes
Stephen D. Wiviott et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Current strategies for ischemic stroke prevention: role of multimodal combination therapies
Mark J. Alberts et al.
JOURNAL OF NEUROLOGY (2007)
Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus - A meta-analysis of randomized trials
A. Michael Lincoff et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Physical activity and public health - Updated recommendation for adults from the American college of sports medicine and the American heart association
William L. Haskell et al.
CIRCULATION (2007)
Family history of premature coronary heart disease and coronary artery calcification - Multi-Ethnic Study of Atherosclerosis (MESA)
Khurram Nasir et al.
CIRCULATION (2007)
Explaining the decrease in US deaths from coronary disease, 1980-2000
Earl S. Ford et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Treatment of hypertension in the prevention and management of ischemic heart disease - A scientific statement from the American Heart Association Council for High Blood Pressure Research and the Councils on Clinical Cardiology and Epidemiology and Prevention
Clive Rosendorff et al.
CIRCULATION (2007)
Development and validation of improved algorithms for the assessment of global cardiovascular risk in women - The Reynolds Risk Score
Paul M. Ridker et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Primary prevention of cardiovascular diseases in people with diabetes mellitus - A scientific statement from the American Heart Association and the American Diabetes Association
John B. Buse et al.
CIRCULATION (2007)
Risks associated with statin therapy - A systematic overview of randomized clinical trials
Amir Kashani et al.
CIRCULATION (2006)
Efficacy of varenicline, an α4β2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation -: A randomized controlled trial
Douglas E. Jorenby et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
High-dose atorvastatin vs usual dose simvastatin for secondary prevention after myocardial infarction - The IDEAL study: A randomized controlled trial
TR Pedersen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial
ZM Chen et al.
LANCET (2005)
Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study):: randomised controlled trial
A Keech et al.
LANCET (2005)
Intensive lipid lowering with atorvastatin in patients with stable coronary disease
JC LaRosa et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation
MS Sabatine et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Intensive versus moderate lipid lowering with statins after acute coronary syndromes
CP Cannon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes - Phase Z of the A to Z trial
JA de Lemos et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study
S Yusuf et al.
LANCET (2004)
The distribution of 10-year risk for coronary heart disease among US adults - Findings from the National Health and Nutrition Examination Survey III
ES Ford et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2004)
Mortality risk reduction associated with smoking cessation in patients with coronary heart disease - A systematic review
JA Critchley et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure - The JNC 7 Report
AV Chobanian et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm (ASCOT-LLA):: a multicentre randomised controlled trial
PS Sever et al.
LANCET (2003)
Multi-ethnic study of atherosclerosis: Objectives and design
DE Bild et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2002)
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20536 high-risk individuals: a randomised placebo-controlled trial
R Collins et al.
LANCET (2002)
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
WC Knowler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
JI Cleeman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance.
J Tuomilehto et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes - The MIRACL study: A randomized controlled trial
GG Schwartz et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Physical activity and mortality in older men with diagnosed coronary heart disease
SG Wannamethee et al.
CIRCULATION (2000)
分享论文
